Abstract
The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI) Predicts Survival and Tolerance of Ibrutinib Therapy in Patients with CLL: A Multicenter Retrospective Cohort Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have